Ad is loading...
CMCAF
Price
$11.18
Change
-$0.00 (-0.00%)
Updated
Oct 24 closing price
RENE
Price
$11.66
Change
+$0.05 (+0.43%)
Updated
Nov 15 closing price
Ad is loading...

CMCAF vs RENE

Header iconCMCAF vs RENE Comparison
Open Charts CMCAF vs RENEBanner chart's image
Capitalworks Emerging Markets Acquisition
Price$11.18
Change-$0.00 (-0.00%)
Volume$126
CapitalizationN/A
Cartesian Growth
Price$11.66
Change+$0.05 (+0.43%)
Volume$127
CapitalizationN/A
CMCAF vs RENE Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMCAF vs. RENE commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMCAF is a Sell and RENE is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CMCAF: $11.18 vs. RENE: $11.66)
Brand notoriety: CMCAF and RENE are both not notable
Both companies represent the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: CMCAF: 79% vs. RENE: 0%
Market capitalization -- CMCAF: $110.08M vs. RENE: $239.99M
CMCAF [@Financial Conglomerates] is valued at $110.08M. RENE’s [@Financial Conglomerates] market capitalization is $239.99M. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $590.24B to $0. The average market capitalization across the [@Financial Conglomerates] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMCAF’s FA Score shows that 0 FA rating(s) are green whileRENE’s FA Score has 0 green FA rating(s).

  • CMCAF’s FA Score: 0 green, 5 red.
  • RENE’s FA Score: 0 green, 5 red.
According to our system of comparison, both CMCAF and RENE are a bad buy in the long-term.

Price Growth

CMCAF (@Financial Conglomerates) experienced а 0.00% price change this week, while RENE (@Financial Conglomerates) price change was -0.09% for the same time period.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.64%. For the same industry, the average monthly price growth was -0.12%, and the average quarterly price growth was +18.55%.

Reported Earning Dates

RENE is expected to report earnings on May 05, 2023.

Industries' Descriptions

@Financial Conglomerates (+0.64% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

FUNDAMENTALS
Fundamentals
RENE($240M) has a higher market cap than CMCAF($110M). CMCAF has higher P/E ratio than RENE: CMCAF (57.95) vs RENE (27.07). RENE YTD gains are higher at: 6.581 vs. CMCAF (2.805). RENE has higher annual earnings (EBITDA): -2.03M vs. CMCAF (-2.37M). CMCAF has more cash in the bank: 122K vs. RENE (50.9K). CMCAF has less debt than RENE: CMCAF (2.07M) vs RENE (3.98M). CMCAF (0) and RENE (0) have equivalent revenues.
CMCAFRENECMCAF / RENE
Capitalization110M240M46%
EBITDA-2.37M-2.03M116%
Gain YTD2.8056.58143%
P/E Ratio57.9527.07214%
Revenue00-
Total Cash122K50.9K240%
Total Debt2.07M3.98M52%
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTC10.680.28
+2.69%
Benitec Biopharma
OPK1.640.02
+1.23%
OPKO Health
CXT55.490.20
+0.36%
Crane NXT Co
BALL60.92-1.02
-1.65%
Ball Corp
FLGC1.17-0.14
-10.69%
Flora Growth Corp

CMCAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMCAF has been loosely correlated with SVII. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMCAF jumps, then SVII could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMCAF
1D Price
Change %
CMCAF100%
N/A
SVII - CMCAF
37%
Loosely correlated
-0.53%
NSTD - CMCAF
34%
Loosely correlated
N/A
RENE - CMCAF
32%
Poorly correlated
+0.43%
SPKLU - CMCAF
28%
Poorly correlated
N/A
ALSA - CMCAF
28%
Poorly correlated
+0.93%
More

RENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENE has been loosely correlated with FNVT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RENE jumps, then FNVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENE
1D Price
Change %
RENE100%
+0.43%
FNVT - RENE
45%
Loosely correlated
N/A
LATG - RENE
33%
Poorly correlated
N/A
CMCAF - RENE
32%
Poorly correlated
N/A
HYAC - RENE
31%
Poorly correlated
-0.09%
BRAC - RENE
28%
Poorly correlated
-0.78%
More